You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chimeric antigen receptor (CAR)

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Kunming (Anti-CLL1 CART cells)

Recruiting
  • Acute Myeloid Leukemia
  • Anti-CLL1 CART cells
  • Kunming, Yunnan, China
    No.212 Daguan Road, Xishan District
Nov 23, 2022

Ependymoma Trial in New York (HER2 Specific CAR T Cell)

Recruiting
  • Ependymoma
  • HER2 Specific CAR T Cell
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 6, 2022

Colorectal Cancer, Esophagus Cancer, Gastric Cancer Trial in Hangzhou (CEA-targeted CAR-T cells)

Recruiting
  • Colorectal Cancer
  • +6 more
  • CEA-targeted CAR-T cells
  • Hangzhou, Zhejiang, China
  • +1 more
Sep 18, 2023

Recurrent Glioblastoma, Recurrent Malignant Glioma, Recurrent WHO Grade II Glioma Trial in Duarte (Chlorotoxin

Recruiting
  • Recurrent Glioblastoma
  • +3 more
  • Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT delivery)
  • Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT/ICV dual delivery)
  • Duarte, California
    City of Hope Medical Center
Feb 25, 2022

Lymphoma, Leukemia, Plasma Cell Dyscrasia Trial in San Francisco (Web Application)

Not yet recruiting
  • Lymphoma
  • +2 more
  • Web Application
  • San Francisco, California
    University of California, San Francisco
Oct 4, 2022

Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in United States (IMPT-314)

Not yet recruiting
  • Relapsed Non-Hodgkin Lymphoma
  • Refractory Non-Hodgkin Lymphoma
  • Los Angeles, California
  • +3 more
Apr 12, 2023

Lymphoma, Lymphoma, Non-Hodgkin, Immune System Diseases Trial in Chapel Hill (ATLCAR.CD30 cells)

Recruiting
  • Lymphoma
  • +7 more
  • ATLCAR.CD30 cells
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Dec 2, 2022

Immunotherapy, Multiple Myeloma Trial in Zhengzhou (Chimeric Antigen Receptor NK Cell Injection Targeting BCMA (BCMA CAR-NK))

Recruiting
  • Immunotherapy
  • Multiple Myeloma
  • Chimeric Antigen Receptor NK Cell Injection Targeting BCMA (BCMA CAR-NK)
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Dec 14, 2022

SLE (Systemic Lupus) Trial in Bangkok (CAR T-cell therapy)

Not yet recruiting
  • SLE (Systemic Lupus)
  • CAR T-cell therapy
  • Bangkok, Please Select, Thailand
    King Chulalongkorn Memorial Hospital
Nov 23, 2023

Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited Trial in Zhengzhou (ThisCART19A, Fludarabine Pill, Cyclophosphamide)

Not yet recruiting
  • Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited
  • Zhengzhou, Henan, China
    Henan cancer hospital
Nov 28, 2022

Sarcoma, HER-2 Protein Overexpression Trial in Houston (cells, Pembrolizumab Injectable Product, Nivolumab Injectable Product)

Recruiting
  • Sarcoma
  • HER-2 Protein Overexpression
  • cells
  • +3 more
  • Houston, Texas
    Texas Children's Hospital
Dec 8, 2021

Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)

Not yet recruiting
  • Chronic Graft Versus Host Disease
  • +2 more
  • Biopsy
  • +11 more
  • Duarte, California
    City of Hope Medical Center
Aug 7, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Duarte

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Apr 5, 2023

B Cell ALL, B-Cell Lymphoma, B-cell Non Hodgkin Lymphoma Trial in Hackensack, New York (Anakinra)

Recruiting
  • B Cell ALL
  • +2 more
  • Hackensack, New Jersey
  • +1 more
Aug 22, 2022

Glioma of Spinal Cord, Glioma of Brainstem Trial in Stanford (GD2 CAR T cells, Fludarabine, Cyclophosphamide)

Recruiting
  • Glioma of Spinal Cord
  • Glioma of Brainstem
  • GD2 CAR T cells
  • +2 more
  • Stanford, California
    Lucile Packard Children's Hospital (LPCH)
Jun 22, 2022

Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Leukemia, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (CAR

Recruiting
  • Lymphoblastic Leukemia, Acute, Childhood
  • +6 more
  • CAR T-cell therapy
  • Singapore, Singapore
    Allen Yeoh Eng Juh
Sep 7, 2021

Lymphoma Non-Hodgkin, Agressive Lymphoma, Diffuse-large B-cell Lymphoma (DLBCL) Trial in Canada, United States (CC-97540)

Active, not recruiting
  • Lymphoma Non-Hodgkin
  • +2 more
  • CC-97540
  • Birmingham, Alabama
  • +13 more
Oct 28, 2022

Non Hodgkin Lymphoma Trial in San Francisco (Neuropsychological testing)

Not yet recruiting
  • Non Hodgkin Lymphoma
  • Neuropsychological testing
  • San Francisco, California
    Stanford Cancer Center
Nov 9, 2022

MT2017-45: CAR-T Cell Therapy for Heme Malignancies

Recruiting
  • Acute Lymphoblastic Leukemia
  • Large B-cell Lymphoma
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 2, 2022

B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • Cyclophosphamide injection
  • +2 more
  • Charleston, South Carolina
    Hollings Cancer Center at Medical University of South Carolina
Jan 18, 2023

Advanced Glioma, Complication of Chimeric Antigen Receptor (CAR-T) Cell Therapy Trial in Suzhou (Targeted IL-13 Ra2 UCAR-T cell

Recruiting
  • Advanced Glioma
  • Complication of Chimeric Antigen Receptor (CAR-T) Cell Therapy
  • Targeted IL-13 Rα2 UCAR-T cell injection
  • Targeted B7-H3 UCAR-T cell injection
  • Suzhou, Jiangsu, China
    The Second Affiliated Hospital of Soochow University
Mar 2, 2023

Malignant Tumor, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Duarte

Recruiting
  • Malignant Neoplasm
  • +4 more
  • Chimeric Antigen Receptor T-Cell Therapy
  • Duarte, California
    City of Hope Medical Center
Sep 14, 2022

Large B-cell Lymphoma Trial in Shanghai (BZ019)

Recruiting
  • Large B-cell Lymphoma
  • BZ019
  • Shanghai, Shanghai, China
    Shanghai Mengchao Cancer Hospital
Jul 21, 2022

Leukemia, Lymphoma, Lymphoma, B-Cell Trial in New York (CAR T-Cell Infusion)

Withdrawn
  • Leukemia
  • +2 more
  • CAR T-Cell Infusion
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 4, 2022

Mantle Cell Lymphoma, Follicular Lymphoma, Splenic Marginal Zone Lymphoma Trial in Chapel Hill (CAR.k.28, Fludarabine,

Recruiting
  • Mantle Cell Lymphoma
  • +5 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Nov 19, 2021